HYALO4 CARE START
UNIQUE FORMULATION FOR PROMOTION OF HEALING AND SELECTIVE WOUND BED PREPARATION
composition
Hyaluronic Acid Sodium Salt 0.2% Collagenase from Vibrio alginolyticus
Packaging Details
Ointment | 30 g Tube for topical use
Classification
Class III – Medical Device – CE0373
INDICATIONS
DIABETIC ULCERS
PRESSURE SORES
VASCULAR ULCERS OF LEGS
ADVANTAGES
- Promotes the natural repair process and protects the periwound skin7
- More rapid wound bed cleansing and healing versus Clostridium histolyticum-based collagenase6
- Promotion of vascularized tissue and reduces formation of fibrin and exudate7
- Specific action with no dermatitis around the wound5
- Reduced pain referred by patients versus Clostridium histolyticum-based collagenase6
FIDIA ADVANCED WOUND CARE SOLUTIONS
References:
1. HYALO4 CARE START instruction for use;
2.xxxxxxxxxxxxxxxxxxxxxxxxxxxxx
3. Di Pasquale R, Vaccaro S, Caputo M, et al. Collagenase-assisted wound bed preparation: An in vitro comparison
between Vibrio alginolyticus and Clostridium histolyticum collagenases on substrate specificity. Int Wound J. 2019;1–11
4. Onesti MG, Fioramonti P, Fino P, Sorvillo V, Carella S, Scuderi N. Effect of enzymatic debridement with two different collagenases versus mechanical debridement on chronic hard-to-heal wounds. Int Wound J. 2016;13(6):1111-5
5. Scalise A, Campitiello F, Della Corte A, et al. Enzymatic debridement: is HA-collagenase the right synergy? Randomized double-blind controlled clinical trial in venous leg ulcers. Eur Rev Med Pharmacol Sci. 2017;21(6):1421-31